Barely Significant
← all excerpts

Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre.

Br J Cancer · 2023 · PMC10006213 · PMID 36572733

Europe PMCDOI
1
hedged sentence
0.1509
closest p · 3.0× alpha
0.1509
boldest claim

The sentences

did not reach statistical significanceP = 0.1509not close (p > 0.1)
Altogether, a median PFS of 4.20 months was obtained for MTB therapies as opposed to 2.83 months for alternative treatments, which did not reach statistical significance (95% CI of ratio 0.8762 to 2.508; P = 0.1509; Fig. 4c ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.